Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Abstract Background Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are required to optimize medical care. The aim of the pres...

Full description

Bibliographic Details
Main Authors: Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, Wilfried Gouraud, Jean-Luc Canon, Andrea Gombos, Florence Dalenc, Suzette Delaloge, Jérôme Lemonnier, Delphine Loussouarn, Véronique Verrièle, Mario Campone
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Triple-negative
Transcriptomics
Molecular subtypes
Immunome
Tertiary lymphoid structures
Online Access:http://link.springer.com/article/10.1186/s13058-019-1148-6

Internet

http://link.springer.com/article/10.1186/s13058-019-1148-6

Similar Items